The market is segmented based on , By Strains (DENV-2, DENV-3, DENV-1, DENV-4, and Others), Type (Vaccines and Acetaminophen), Severity (Mild to Moderate Dengue and Severe Dengue), Route of Administration (Parenteral and Oral), Mode of Purchase (Prescription and Over-the-Counter (OTC)), Gender (Male and Female), Age (Adult, Pediatric, and Geriatric), End User (Hospital, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Industry Trends and Forecast to 2031.
.
The Global Dengue Treatment Market size was valued at USD 878.54 USD Million in 2023.
The Global Dengue Treatment Market is projected to grow at a CAGR of 11.6% during the forecast period of 2024 to 2031.
The major players operating in the market include sanofi, Takeda Pharmaceutical Company Limited, Viatris Inc., Johnson & Johnson Services, Inc., GSK plc., Perrigo Company PLC, Baxter, Fresenius Kabi USA, Pfizer, Hikma Pharmaceuticals Plc, SUN PHARMACEUTICAL INDUSTRIES LTD, Teva Pharmaceuticals USA, Inc., and Aurobindo Pharma among others.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.